About yuri Yuri is a longevity biotech entrepreneur specializing in early-stage translation of scientific breakthroughs into therapies, particularly in the CNS space: previously, Yuri has led several early-stage pharmaceutical startups, including one developing an Alzheimer's therapeutic, and another developing small-molecule neuroprotectors for Alzheimer's, Parkinson's, and a rare pediatric disease. Currently, Yuri is leading YouthBio Therapeutics, which is developing epigenetic rejuvenation gene therapies based on partial cellular reprogramming by Yamanaka factors.
